Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma

Bibliographic Details
Main Authors: Liezel L. Griffin, MBBS, Laura Cove-Smith, PhD, Hana Alachkar, MD, John A. Radford, MD, Rebecca Brooke, MD, Kim M. Linton, PhD
Format: Article
Language:English
Published: Elsevier 2018-04-01
Series:JAAD Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512617302370
id doaj-76bbb4d0e0e34251a8a68bf5859568b5
record_format Article
spelling doaj-76bbb4d0e0e34251a8a68bf5859568b52020-11-24T22:07:39ZengElsevierJAAD Case Reports2352-51262018-04-0143229231Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphomaLiezel L. Griffin, MBBS0Laura Cove-Smith, PhD1Hana Alachkar, MD2John A. Radford, MD3Rebecca Brooke, MD4Kim M. Linton, PhD5Dermatology Centre, Salford Royal NHS Foundation Trust, Salford, United KingdomManchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United KingdomDepartment of Immunology, Salford Royal NHS Foundation Trust, Salford, United KingdomManchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United KingdomDermatology Centre, Salford Royal NHS Foundation Trust, Salford, United KingdomManchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Correspondence to: Kim M. Linton, PhD, Senior Lecturer and Honorary Consultant in Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, United Kingdom.http://www.sciencedirect.com/science/article/pii/S2352512617302370
collection DOAJ
language English
format Article
sources DOAJ
author Liezel L. Griffin, MBBS
Laura Cove-Smith, PhD
Hana Alachkar, MD
John A. Radford, MD
Rebecca Brooke, MD
Kim M. Linton, PhD
spellingShingle Liezel L. Griffin, MBBS
Laura Cove-Smith, PhD
Hana Alachkar, MD
John A. Radford, MD
Rebecca Brooke, MD
Kim M. Linton, PhD
Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma
JAAD Case Reports
author_facet Liezel L. Griffin, MBBS
Laura Cove-Smith, PhD
Hana Alachkar, MD
John A. Radford, MD
Rebecca Brooke, MD
Kim M. Linton, PhD
author_sort Liezel L. Griffin, MBBS
title Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma
title_short Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma
title_full Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma
title_fullStr Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma
title_full_unstemmed Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma
title_sort toxic epidermal necrolysis (ten) associated with the use of nivolumab (pd-1 inhibitor) for lymphoma
publisher Elsevier
series JAAD Case Reports
issn 2352-5126
publishDate 2018-04-01
url http://www.sciencedirect.com/science/article/pii/S2352512617302370
work_keys_str_mv AT liezellgriffinmbbs toxicepidermalnecrolysistenassociatedwiththeuseofnivolumabpd1inhibitorforlymphoma
AT lauracovesmithphd toxicepidermalnecrolysistenassociatedwiththeuseofnivolumabpd1inhibitorforlymphoma
AT hanaalachkarmd toxicepidermalnecrolysistenassociatedwiththeuseofnivolumabpd1inhibitorforlymphoma
AT johnaradfordmd toxicepidermalnecrolysistenassociatedwiththeuseofnivolumabpd1inhibitorforlymphoma
AT rebeccabrookemd toxicepidermalnecrolysistenassociatedwiththeuseofnivolumabpd1inhibitorforlymphoma
AT kimmlintonphd toxicepidermalnecrolysistenassociatedwiththeuseofnivolumabpd1inhibitorforlymphoma
_version_ 1725819314699763712